Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Lung Cancer (Amsterdam, Netherlands)|October 5, 2007
Non-small cell lung carcinoma of the superior sulcus: favourable outcomes of combined modality treatment in carefully selected patientsI Kappers, J S A Belderbos, J A Burgers, et al.
The Pharmacogenomics Journal|July 26, 2005
Genetic factors influencing pyrimidine-antagonist chemotherapyJ G Maring, H J M Groen, F M Wachters, et al.
Journal of Clinical Pathology|February 21, 2006
Differential expression and distribution of epithelial adhesion molecules in non-small cell lung cancer and normal bronchusM C Boelens, A van den Berg, I Vogelzang, et al.
Critical Reviews in Oncology/Hematology|February 8, 2016
Resistance mechanisms after tyrosine kinase inhibitors afatinib and crizotinib in non-small cell lung cancer, a review of the literatureA J van der Wekken, A Saber, T J N Hiltermann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 13, 2015
Variation in causes of death in patients with non-small cell lung cancer according to stage and time since diagnosisM L G Janssen-Heijnen, F N van Erning, D K De Ruysscher, et al.
British Journal of Cancer|December 15, 2004
A randomised phase II trial of docetaxel vs docetaxel and irinotecan in patients with stage IIIb-IV non-small-cell lung cancer who failed first-line treatmentF M Wachters, H J M Groen, B Biesma, et al.
Lung Cancer (Amsterdam, Netherlands)|January 9, 2008
Irinotecan and cisplatin with concurrent thoracic radiotherapy in a once-every-three-weeks schedule in patients with limited-disease small-cell lung cancer: a phase I studyW K de Jong, M J A de Jonge, A H D van der Leest, et al.
Pathology, Research and Practice|October 21, 2021
Immune related endonucleases and GTPases are not associated with tumor response in patients with advanced non-small cell lung cancer treated with checkpoint inhibitorsH O Ramdani, M Falk, L C Heukamp, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2010
Chemotherapy in elderly small-cell lung cancer patients: yes we can, but should we do it?M L G Janssen-Heijnen, H A A M Maas, S A M van de Schans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2011
Treatment and survival of patients with small-cell lung cancer: small steps forward, but not for patients >80M L G Janssen-Heijnen, H A A M Maas, S Siesling, et al.
Pageof 7